ArticleClinical science (London, England : 1979)2019

STAT1-mediated inhibition of FOXM1 enhances gemcitabine sensitivity in pancreatic cancer.

Chao Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.